Mapping the Evidence on the Effectiveness of Telemedicine Interventions in Diabetes, Dyslipidemia, and Hypertension: An Umbrella Review of Systematic Reviews and Meta-Analyses

Patrick Timpel, Sarah Oswald, Peter E H Schwarz, Lorenz Harst, Patrick Timpel, Sarah Oswald, Peter E H Schwarz, Lorenz Harst

Abstract

Background: Telemedicine is defined by three characteristics: (1) using information and communication technologies, (2) covering a geographical distance, and (3) involving professionals who deliver care directly to a patient or a group of patients. It is said to improve chronic care management and self-management in patients with chronic diseases. However, currently available guidelines for the care of patients with diabetes, hypertension, or dyslipidemia do not include evidence-based guidance on which components of telemedicine are most effective for which patient populations.

Objective: The primary aim of this study was to identify, synthesize, and critically appraise evidence on the effectiveness of telemedicine solutions and their components on clinical outcomes in patients with diabetes, hypertension, or dyslipidemia.

Methods: We conducted an umbrella review of high-level evidence, including systematic reviews and meta-analyses of randomized controlled trials. On the basis of predefined eligibility criteria, extensive automated and manual searches of the databases PubMed, EMBASE, and Cochrane Library were conducted. Two authors independently screened the studies, extracted data, and carried out the quality assessments. Extracted data were presented according to intervention components and patient characteristics using defined thresholds of clinical relevance. Overall certainty of outcomes was assessed using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) tool.

Results: Overall, 3564 references were identified, of which 46 records were included after applying eligibility criteria. The majority of included studies were published after 2015. Significant and clinically relevant reduction rates for glycated hemoglobin (HbA1c; ≤-0.5%) were found in patients with diabetes. Higher reduction rates were found for recently diagnosed patients and those with higher baseline HbA1c (>8%). Telemedicine was not found to have a significant and clinically meaningful impact on blood pressure. Only reviews or meta-analyses reporting lipid outcomes in patients with diabetes were found. GRADE assessment revealed that the overall quality of the evidence was low to very low.

Conclusions: The results of this umbrella review indicate that telemedicine has the potential to improve clinical outcomes in patients with diabetes. Although subgroup-specific effectiveness rates favoring certain intervention and population characteristics were found, the low GRADE ratings indicate that evidence can be considered as limited. Future updates of clinical care and practice guidelines should carefully assess the methodological quality of studies and the overall certainty of subgroup-specific outcomes before recommending telemedicine interventions for certain patient populations.

Keywords: GRADE approach; diabetes mellitus; dyslipidemia; hypertension; review; telemedicine; treatment outcome.

Conflict of interest statement

Conflicts of Interest: None declared.

©Patrick Timpel, Sarah Oswald, Peter E H Schwarz, Lorenz Harst. Originally published in the Journal of Medical Internet Research (http://www.jmir.org), 18.03.2020.

Figures

Figure 1
Figure 1
Preferred Reporting Items for Systematic Reviews and Meta-analyses flowchart of the study selection process. OQAQ: Overview Quality Assessment Questionnaire.

References

    1. Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, Colagiuri S, Guariguata L, Motala AA, Ogurtsova K, Shaw JE, Bright D, Williams R, IDF Diabetes Atlas Committee Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9 edition. Diabetes Res Clin Pract. 2019 Nov;157:107843. doi: 10.1016/j.diabres.2019.107843.
    1. Iglay K, Hannachi H, Joseph Howie P, Xu J, Li X, Engel SS, Moore LM, Rajpathak S. Prevalence and co-prevalence of comorbidities among patients with type 2 diabetes mellitus. Curr Med Res Opin. 2016 Jul;32(7):1243–52. doi: 10.1185/03007995.2016.1168291.
    1. Song Y, Liu X, Zhu X, Zhao B, Hu B, Sheng X, Chen L, Yu M, Yang T, Zhao J. Increasing trend of diabetes combined with hypertension or hypercholesterolemia: NHANES data analysis 1999-2012. Sci Rep. 2016 Nov 2;6:36093. doi: 10.1038/srep36093. doi: 10.1038/srep36093.
    1. Schwarz PE, Timpel P, Harst L, Greaves CJ, Ali MK, Lambert J, Weber MB, Almedawar MM, Morawietz H. Blood sugar regulation for cardiovascular health promotion and disease prevention: JACC health promotion series. J Am Coll Cardiol. 2018 Oct 9;72(15):1829–44. doi: 10.1016/j.jacc.2018.07.081.
    1. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998 Sep 12;352(9131):837–53.
    1. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. Br Med J. 1998 Sep 12;317(7160):703–13.
    1. Turnbull F, Neal B, Algert C, Chalmers J, Chapman N, Cutler J, Woodward M, MacMahon S, Blood Pressure Lowering Treatment Trialists' Collaboration Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trials. Arch Intern Med. 2005 Jun 27;165(12):1410–9. doi: 10.1001/archinte.165.12.1410.
    1. Thomopoulos C, Parati G, Zanchetti A. Effects of blood-pressure-lowering treatment on outcome incidence in hypertension: 10 - Should blood pressure management differ in hypertensive patients with and without diabetes mellitus? Overview and meta-analyses of randomized trials. J Hypertens. 2017 May;35(5):922–44. doi: 10.1097/HJH.0000000000001276.
    1. Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, Kirby A, Sourjina T, Peto R, Collins R, Simes R, Cholesterol Treatment Trialists' (CTT) Collaborators Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet. 2005 Oct 8;366(9493):1267–78. doi: 10.1016/S0140-6736(05)67394-1.
    1. ADVANCE Collaborative Group. Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, Marre M, Cooper M, Glasziou P, Grobbee D, Hamet P, Harrap S, Heller S, Liu L, Mancia G, Mogensen CE, Pan C, Poulter N, Rodgers A, Williams B, Bompoint S, de Galan BE, Joshi R, Travert F. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008 Jun 12;358(24):2560–72. doi: 10.1056/NEJMoa0802987.
    1. American Diabetes Association 9. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes-2018. Diabetes Care. 2018 Jan;41(Suppl 1):S86–104. doi: 10.2337/dc18-S009.
    1. Beck J, Greenwood DA, Blanton L, Bollinger ST, Butcher MK, Condon JE, Cypress M, Faulkner P, Fischl AH, Francis T, Kolb LE, Lavin-Tompkins JM, MacLeod J, Maryniuk M, Mensing C, Orzeck EA, Pope DD, Pulizzi JL, Reed AA, Rhinehart AS, Siminerio L, Wang J, 2017 Standards Revision Task Force 2017 National Standards for Diabetes Self-Management Education and Support. Diabetes Care. 2017 Oct;40(10):1409–19. doi: 10.2337/dci17-0025.
    1. He X, Li J, Wang B, Yao Q, Li L, Song R, Shi X, Zhang J. Diabetes self-management education reduces risk of all-cause mortality in type 2 diabetes patients: a systematic review and meta-analysis. Endocrine. 2017 Mar;55(3):712–31. doi: 10.1007/s12020-016-1168-2.
    1. Sherifali D, Bai J, Kenny M, Warren R, Ali MU. Diabetes self-management programmes in older adults: a systematic review and meta-analysis. Diabet Med. 2015 Nov;32(11):1404–14. doi: 10.1111/dme.12780.
    1. Williams B, Mancia G, Spiering W, Rosei EA, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, Kahan T, Mahfoud F, Redon J, Ruilope L, Zanchetti A, Kerins M, Kjeldsen SE, Kreutz R, Laurent S, Lip GY, McManus R, Narkiewicz K, Ruschitzka F, Schmieder RE, Shlyakhto E, Tsioufis C, Aboyans V, Desormais I, ESC Scientific Document Group 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018 Sep 1;39(33):3021–104. doi: 10.1093/eurheartj/ehy339.
    1. Otto L, Harst L, Schlieter H, Wollschlaeger B, Richter P, Timpel P. Towards a Unified Understanding of eHealth and Related Terms – Proposal of a Consolidated Terminological Basis. Proceedings of the 11th International Joint Conference on Biomedical Engineering Systems and Technologies; BIOSTEC'18; Jan 19-21, 2018; Funchal, Madeira, Portugal. Health Informatics Europe; 2018; Madeira: HEALTHINF; 2018. pp. 533–9.
    1. Sood S, Mbarika V, Jugoo S, Dookhy R, Doarn CR, Prakash N, Merrell RC. What is telemedicine? A collection of 104 peer-reviewed perspectives and theoretical underpinnings. Telemed J E Health. 2007 Oct;13(5):573–90. doi: 10.1089/tmj.2006.0073.
    1. Kruse CS, Soma M, Pulluri D, Nemali NT, Brooks M. The effectiveness of telemedicine in the management of chronic heart disease - a systematic review. JRSM Open. 2017 Mar;8(3):2054270416681747. doi: 10.1177/2054270416681747.
    1. Hanlon P, Daines L, Campbell C, McKinstry B, Weller D, Pinnock H. Telehealth interventions to support self-management of long-term conditions: a systematic metareview of diabetes, heart failure, asthma, chronic obstructive pulmonary disease, and cancer. J Med Internet Res. 2017 May 17;19(5):e172. doi: 10.2196/jmir.6688.
    1. American Diabetes Association 5. Prevention or Delay of Type 2 Diabetes: Standards of Medical Care in Diabetes-2018. Diabetes Care. 2018 Jan;41(Suppl 1):S51–4. doi: 10.2337/dc18-S005.
    1. American Diabetes Association 6. Glycemic Targets: Standards of Medical Care in Diabetes-2018. Diabetes Care. 2018 Jan;41(Suppl 1):S55–64. doi: 10.2337/dc18-S006.
    1. Greenwood DA, Gee PM, Fatkin KJ, Peeples M. A systematic review of reviews evaluating technology-enabled diabetes self-management education and support. J Diabetes Sci Technol. 2017 Sep;11(5):1015–27. doi: 10.1177/1932296817713506.
    1. Ekeland AG, Bowes A, Flottorp S. Effectiveness of telemedicine: a systematic review of reviews. Int J Med Inform. 2010 Nov;79(11):736–71. doi: 10.1016/j.ijmedinf.2010.08.006.
    1. Kitsiou S, Paré G, Jaana M, Gerber B. Effectiveness of mHealth interventions for patients with diabetes: An overview of systematic reviews. PLoS One. 2017;12(3):e0173160. doi: 10.1371/journal.pone.0173160.
    1. Ekeland AG, Bowes A, Flottorp S. Methodologies for assessing telemedicine: a systematic review of reviews. Int J Med Inform. 2012 Jan;81(1):1–11. doi: 10.1016/j.ijmedinf.2011.10.009.
    1. Dinesen B, Nonnecke B, Lindeman D, Toft E, Kidholm K, Jethwani K, Young HM, Spindler H, Oestergaard CU, Southard JA, Gutierrez M, Anderson N, Albert NM, Han JJ, Nesbitt T. Personalized Telehealth in the future: a global research agenda. J Med Internet Res. 2016 Mar 1;18(3):e53. doi: 10.2196/jmir.5257.
    1. Kirley K, Sachdev N. Digital health-supported lifestyle change programs to prevent Type 2 Diabetes. Diabetes Spectr. 2018 Nov;31(4):303–9. doi: 10.2337/ds18-0019.
    1. Aromataris E, Fernandez R, Godfrey CM, Holly C, Khalil H, Tungpunkom P. Summarizing systematic reviews: methodological development, conduct and reporting of an umbrella review approach. Int J Evid Based Healthc. 2015 Sep;13(3):132–40. doi: 10.1097/XEB.0000000000000055.
    1. Hunt H, Pollock A, Campbell P, Estcourt L, Brunton G. An introduction to overviews of reviews: planning a relevant research question and objective for an overview. Syst Rev. 2018 Mar 1;7(1):39. doi: 10.1186/s13643-018-0695-8.
    1. Guyatt GH, Oxman AD, Kunz R, Vist GE, Falck-Ytter Y, Schünemann HJ, GRADE Working Group What is 'quality of evidence' and why is it important to clinicians? Br Med J. 2008 May 3;336(7651):995–8. doi: 10.1136/.
    1. Davies MJ, D'Alessio DA, Fradkin J, Kernan WN, Mathieu C, Mingrone G, Rossing P, Tsapas A, Wexler DJ, Buse JB. Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) Diabetes Care. 2018 Dec;41(12):2669–701. doi: 10.2337/dci18-0033.
    1. Catapano AL, Graham I, de Backer G, Wiklund O, Chapman MJ, Drexel H, Hoes AW, Jennings CS, Landmesser U, Pedersen TR, Reiner Ž, Riccardi G, Taskinen M, Tokgozoglu L, Verschuren WM, Vlachopoulos C, Wood DA, Zamorano JL, Cooney MT, ESC Scientific Document Group 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias. Eur Heart J. 2016 Oct 14;37(39):2999–3058. doi: 10.1093/eurheartj/ehw272.
    1. Oxman AD, Guyatt GH. Validation of an index of the quality of review articles. J Clin Epidemiol. 1991;44(11):1271–8. doi: 10.1016/0895-4356(91)90160-b.
    1. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, Schünemann HJ, GRADE Working Group GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. Br Med J. 2008 Apr 26;336(7650):924–6. doi: 10.1136/.
    1. Higgins J, Green S. Cochrane Handbook for Systematic Reviews of Interventions. Hoboken, New Jersey, United States: Wiley; 2019.
    1. Little RR, Rohlfing CL, Sacks DB, National Glycohemoglobin Standardization Program (NGSP) Steering Committee Status of hemoglobin A1c measurement and goals for improvement: from chaos to order for improving diabetes care. Clin Chem. 2011 Feb;57(2):205–14. doi: 10.1373/clinchem.2010.148841.
    1. Chrvala CA, Sherr D, Lipman RD. Diabetes self-management education for adults with type 2 diabetes mellitus: a systematic review of the effect on glycemic control. Patient Educ Couns. 2016 Jun;99(6):926–43. doi: 10.1016/j.pec.2015.11.003.
    1. Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. Br Med J. 2009 May 19;338:b1665. doi: 10.1136/bmj.b1665.
    1. Schünemann H, Brożek J, Guyatt G, Oxman A. GRADEpro GDT. 2013. [2020-01-16]. GRADE Handbook for Grading Quality of Evidence and Strength of Recommendations .
    1. Alessa T, Abdi S, Hawley MS, de Witte L. Mobile apps to support the self-management of hypertension: systematic review of effectiveness, usability, and user satisfaction. JMIR Mhealth Uhealth. 2018 Jul 23;6(7):e10723. doi: 10.2196/10723.
    1. Aspry KE, Furman R, Karalis DG, Jacobson TA, Zhang AM, Liptak GS, Cohen JD. Effect of health information technology interventions on lipid management in clinical practice: a systematic review of randomized controlled trials. J Clin Lipidol. 2013;7(6):546–60. doi: 10.1016/j.jacl.2013.10.004.
    1. Baron J, McBain H, Newman S. The impact of mobile monitoring technologies on glycosylated hemoglobin in diabetes: a systematic review. J Diabetes Sci Technol. 2012 Sep 1;6(5):1185–96. doi: 10.1177/193229681200600524.
    1. Connelly J, Kirk A, Masthoff J, MacRury S. The use of technology to promote physical activity in Type 2 diabetes management: a systematic review. Diabet Med. 2013 Dec;30(12):1420–32. doi: 10.1111/dme.12289.
    1. de Jongh T, Gurol-Urganci I, Vodopivec-Jamsek V, Car J, Atun R. Mobile phone messaging for facilitating self-management of long-term illnesses. Cochrane Database Syst Rev. 2012 Dec 12;12:CD007459. doi: 10.1002/14651858.CD007459.pub2.
    1. El-Gayar O, Timsina P, Nawar N, Eid W. A systematic review of IT for diabetes self-management: are we there yet? Int J Med Inform. 2013 Aug;82(8):637–52. doi: 10.1016/j.ijmedinf.2013.05.006.
    1. Farmer AJ, McSharry J, Rowbotham S, McGowan L, Ricci-Cabello I, French DP. Effects of interventions promoting monitoring of medication use and brief messaging on medication adherence for people with Type 2 diabetes: a systematic review of randomized trials. Diabet Med. 2016 May;33(5):565–79. doi: 10.1111/dme.12987.
    1. Fu H, McMahon SK, Gross CR, Adam TJ, Wyman JF. Usability and clinical efficacy of diabetes mobile applications for adults with type 2 diabetes: a systematic review. Diabetes Res Clin Pract. 2017 Sep;131:70–81. doi: 10.1016/j.diabres.2017.06.016.
    1. Holmen H, Wahl AK, Småstuen MC, Ribu L. Tailored communication within mobile apps for diabetes self-management: a systematic review. J Med Internet Res. 2017 Jun 23;19(6):e227. doi: 10.2196/jmir.7045.
    1. Mushcab H, Kernohan WG, Wallace J, Martin S. Web-based remote monitoring systems for self-managing Type 2 Diabetes: a systematic review. Diabetes Technol Ther. 2015 Jul;17(7):498–509. doi: 10.1089/dia.2014.0296.
    1. Paré G, Moqadem K, Pineau G, St-Hilaire C. Clinical effects of home telemonitoring in the context of diabetes, asthma, heart failure and hypertension: a systematic review. J Med Internet Res. 2010 Jun 16;12(2):e21. doi: 10.2196/jmir.1357.
    1. Porter J, Huggins CE, Truby H, Collins J. The effect of using mobile technology-based methods that record food or nutrient intake on diabetes control and nutrition outcomes: a systematic review. Nutrients. 2016 Dec 17;8(12):pii: E815. doi: 10.3390/nu8120815.
    1. Rush KL, Hatt L, Janke R, Burton L, Ferrier M, Tetrault M. The efficacy of telehealth delivered educational approaches for patients with chronic diseases: A systematic review. Patient Educ Couns. 2018 Aug;101(8):1310–21. doi: 10.1016/j.pec.2018.02.006.
    1. Russell-Minda E, Jutai J, Speechley M, Bradley K, Chudyk A, Petrella R. Health technologies for monitoring and managing diabetes: a systematic review. J Diabetes Sci Technol. 2009 Nov 1;3(6):1460–71. doi: 10.1177/193229680900300628.
    1. Sun C, Malcolm JC, Wong B, Shorr R, Doyle M. Improving glycemic control in adults and children with Type 1 Diabetes with the use of smartphone-based mobile applications: a systematic review. Can J Diabetes. 2019 Feb;43(1):51–8.e3. doi: 10.1016/j.jcjd.2018.03.010.
    1. Vargas G, Cajita MI, Whitehouse E, Han H. Use of short messaging service for hypertension management: a systematic review. J Cardiovasc Nurs. 2017;32(3):260–70. doi: 10.1097/JCN.0000000000000336.
    1. Angeles RN, Howard MI, Dolovich L. The effectiveness of web-based tools for improving blood glucose control in patients with diabetes Mellitus: a meta-analysis. Can J Diabetes. 2011;35(4):344–52. doi: 10.1016/S1499-2671(11)54011-0.
    1. Omboni S, Guarda A. Impact of home blood pressure telemonitoring and blood pressure control: a meta-analysis of randomized controlled studies. Am J Hypertens. 2011 Sep;24(9):989–98. doi: 10.1038/ajh.2011.100.
    1. Omboni S, Gazzola T, Carabelli G, Parati G. Clinical usefulness and cost effectiveness of home blood pressure telemonitoring: meta-analysis of randomized controlled studies. J Hypertens. 2013 Mar;31(3):455–67; discussion 467. doi: 10.1097/HJH.0b013e32835ca8dd.
    1. Shen Y, Wang F, Zhang X, Zhu X, Sun Q, Fisher E, Sun X. Effectiveness of internet-based interventions on glycemic control in patients with Type 2 Diabetes: meta-analysis of randomized controlled trials. J Med Internet Res. 2018 May 7;20(5):e172. doi: 10.2196/jmir.9133.
    1. Su D, Zhou J, Kelley MS, Michaud TL, Siahpush M, Kim J, Wilson F, Stimpson JP, Pagán JA. Does telemedicine improve treatment outcomes for diabetes? A meta-analysis of results from 55 randomized controlled trials. Diabetes Res Clin Pract. 2016 Jun;116:136–48. doi: 10.1016/j.diabres.2016.04.019.
    1. Tchero H, Kangambega P, Briatte C, Brunet-Houdard S, Retali G, Rusch E. Clinical effectiveness of Telemedicine in Diabetes Mellitus: a meta-analysis of 42 randomized controlled trials. Telemed J E Health. 2019 Jul;25(7):569–83. doi: 10.1089/tmj.2018.0128.
    1. Wu C, Wu Z, Yang L, Zhu W, Zhang M, Zhu Q, Chen X, Pan Y. Evaluation of the clinical outcomes of telehealth for managing diabetes: a PRISMA-compliant meta-analysis. Medicine (Baltimore) 2018 Oct;97(43):e12962. doi: 10.1097/MD.0000000000012962. doi: 10.1097/MD.0000000000012962.
    1. Wu Y, Yao X, Vespasiani G, Nicolucci A, Dong Y, Kwong J, Li L, Sun X, Tian H, Li S. Mobile app-based interventions to support diabetes self-management: a systematic review of randomized controlled trials to identify functions associated with glycemic efficacy. JMIR Mhealth Uhealth. 2017 Mar 14;5(3):e35. doi: 10.2196/mhealth.6522.
    1. Alharbi NS, Alsubki N, Jones S, Khunti K, Munro N, de Lusignan S. Impact of Information Technology-based interventions for Type 2 Diabetes Mellitus on glycemic control: a systematic review and meta-analysis. J Med Internet Res. 2016 Nov 25;18(11):e310. doi: 10.2196/jmir.5778.
    1. Bonoto BC, de Araújo VE, Godói IP, de Lemos LL, Godman B, Bennie M, Diniz LM, Junior AA. Efficacy of mobile apps to support the care of patients with Diabetes Mellitus: a systematic review and meta-analysis of randomized controlled trials. JMIR Mhealth Uhealth. 2017 Mar 1;5(3):e4. doi: 10.2196/mhealth.6309.
    1. Cui M, Wu X, Mao J, Wang X, Nie M. T2DM self-management via smartphone applications: a systematic review and meta-analysis. PLoS One. 2016;11(11):e0166718. doi: 10.1371/journal.pone.0166718.
    1. Faruque LI, Wiebe N, Ehteshami-Afshar A, Liu Y, Dianati-Maleki N, Hemmelgarn BR, Manns BJ, Tonelli M, Alberta Kidney Disease Network Effect of telemedicine on glycated hemoglobin in diabetes: a systematic review and meta-analysis of randomized trials. Can Med Assoc J. 2017 Mar 6;189(9):E341–64. doi: 10.1503/cmaj.150885.
    1. Huang Z, Tao H, Meng Q, Jing L. Management of endocrine disease. Effects of telecare intervention on glycemic control in type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. Eur J Endocrinol. 2015 Mar;172(3):R93–101. doi: 10.1530/EJE-14-0441.
    1. Kelly JT, Reidlinger DP, Hoffmann TC, Campbell KL. Telehealth methods to deliver dietary interventions in adults with chronic disease: a systematic review and meta-analysis. Am J Clin Nutr. 2016 Dec;104(6):1693–702. doi: 10.3945/ajcn.116.136333.
    1. Lee SW, Ooi L, Lai YK. Telemedicine for the management of glycemic control and clinical outcomes of Type 1 Diabetes Mellitus: a systematic review and meta-analysis of randomized controlled studies. Front Pharmacol. 2017;8:330. doi: 10.3389/fphar.2017.00330. doi: 10.3389/fphar.2017.00330.
    1. Liu S, Dunford SD, Leung YW, Brooks D, Thomas SG, Eysenbach G, Nolan RP. Reducing blood pressure with internet-based interventions: a meta-analysis. Can J Cardiol. 2013 May;29(5):613–21. doi: 10.1016/j.cjca.2013.02.007.
    1. Marcolino MS, Maia JX, Alkmim MB, Boersma E, Ribeiro AL. Telemedicine application in the care of diabetes patients: systematic review and meta-analysis. PLoS One. 2013;8(11):e79246. doi: 10.1371/journal.pone.0079246.
    1. Pal K, Eastwood SV, Michie S, Farmer A, Barnard ML, Peacock R, Wood B, Edwards P, Murray E. Computer-based interventions to improve self-management in adults with type 2 diabetes: a systematic review and meta-analysis. Diabetes Care. 2014 Jun;37(6):1759–66. doi: 10.2337/dc13-1386.
    1. Polisena J, Tran K, Cimon K, Hutton B, McGill S, Palmer K. Home telehealth for diabetes management: a systematic review and meta-analysis. Diabetes Obes Metab. 2009 Oct;11(10):913–30. doi: 10.1111/j.1463-1326.2009.01057.x.
    1. Saffari M, Ghanizadeh G, Koenig HG. Health education via mobile text messaging for glycemic control in adults with type 2 diabetes: a systematic review and meta-analysis. Prim Care Diabetes. 2014 Dec;8(4):275–85. doi: 10.1016/j.pcd.2014.03.004.
    1. Spencer-Bonilla G, Ponce OJ, Rodriguez-Gutierrez R, Alvarez-Villalobos N, Erwin PJ, Larrea-Mantilla L, Rogers A, Montori VM. A systematic review and meta-analysis of trials of social network interventions in type 2 diabetes. BMJ Open. 2017 Aug 21;7(8):e016506. doi: 10.1136/bmjopen-2017-016506.
    1. Suksomboon N, Poolsup N, Nge YL. Impact of phone call intervention on glycemic control in diabetes patients: a systematic review and meta-analysis of randomized, controlled trials. PLoS One. 2014;9(2):e89207. doi: 10.1371/journal.pone.0089207.
    1. Toma T, Athanasiou T, Harling L, Darzi A, Ashrafian H. Online social networking services in the management of patients with diabetes mellitus: systematic review and meta-analysis of randomised controlled trials. Diabetes Res Clin Pract. 2014 Nov;106(2):200–11. doi: 10.1016/j.diabres.2014.06.008.
    1. Wu IX, Kee JC, Threapleton DE, Ma RC, Lam VC, Lee EK, Wong SY, Chung VC. Effectiveness of smartphone technologies on glycaemic control in patients with type 2 diabetes: systematic review with meta-analysis of 17 trials. Obes Rev. 2018 Jun;19(6):825–38. doi: 10.1111/obr.12669.
    1. Yoshida Y, Boren SA, Soares J, Popescu M, Nielson SD, Simoes EJ. Effect of health information technologies on glycemic control among patients with type 2 diabetes. Curr Diab Rep. 2018 Oct 18;18(12):130. doi: 10.1007/s11892-018-1105-2.
    1. Zhai Y, Zhu W, Cai Y, Sun D, Zhao J. Clinical- and cost-effectiveness of telemedicine in type 2 diabetes mellitus: a systematic review and meta-analysis. Medicine (Baltimore) 2014 Dec;93(28):e312. doi: 10.1097/MD.0000000000000312. doi: 10.1097/MD.0000000000000312.
    1. Hou C, Xu Q, Diao S, Hewitt J, Li J, Carter B. Mobile phone applications and self-management of diabetes: a systematic review with meta-analysis, meta-regression of 21 randomized trials and GRADE. Diabetes Obes Metab. 2018 Aug;20(8):2009–13. doi: 10.1111/dom.13307.
    1. Kebede MM, Zeeb H, Peters M, Heise TL, Pischke CR. Effectiveness of digital interventions for improving glycemic control in persons with poorly controlled type 2 diabetes: a systematic review, meta-analysis, and meta-regression analysis. Diabetes Technol Ther. 2018 Nov;20(11):767–82. doi: 10.1089/dia.2018.0216.
    1. Liang X, Wang Q, Yang X, Cao J, Chen J, Mo X, Huang J, Wang L, Gu D. Effect of mobile phone intervention for diabetes on glycaemic control: a meta-analysis. Diabet Med. 2011 Apr;28(4):455–63. doi: 10.1111/j.1464-5491.2010.03180.x.
    1. Lee SW, Chan CK, Chua SS, Chaiyakunapruk N. Comparative effectiveness of telemedicine strategies on type 2 diabetes management: a systematic review and network meta-analysis. Sci Rep. 2017 Oct 4;7(1):12680. doi: 10.1038/s41598-017-12987-z. doi: 10.1038/s41598-017-12987-z.
    1. Snorgaard O, Poulsen GM, Andersen HK, Astrup A. Systematic review and meta-analysis of dietary carbohydrate restriction in patients with type 2 diabetes. BMJ Open Diabetes Res Care. 2017;5(1):e000354. doi: 10.1136/bmjdrc-2016-000354.
    1. Pai L, Li T, Hwu Y, Chang S, Chen L, Chang P. The effectiveness of regular leisure-time physical activities on long-term glycemic control in people with type 2 diabetes: a systematic review and meta-analysis. Diabetes Res Clin Pract. 2016 Mar;113:77–85. doi: 10.1016/j.diabres.2016.01.011.
    1. Sherifali D, Nerenberg K, Pullenayegum E, Cheng JE, Gerstein HC. The effect of oral antidiabetic agents on A1C levels: a systematic review and meta-analysis. Diabetes Care. 2010 Aug;33(8):1859–64. doi: 10.2337/dc09-1727.
    1. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998 Sep 12;352(9131):854–65.
    1. Pillay J, Armstrong MJ, Butalia S, Donovan LE, Sigal RJ, Vandermeer B, Chordiya P, Dhakal S, Hartling L, Nuspl M, Featherstone R, Dryden DM. Behavioral programs for type 2 diabetes mellitus: a systematic review and network meta-analysis. Ann Intern Med. 2015 Dec 1;163(11):848–60. doi: 10.7326/M15-1400.
    1. Kastner M, Cardoso R, Lai Y, Treister V, Hamid JS, Hayden L, Wong G, Ivers NM, Liu B, Marr S, Holroyd-Leduc J, Straus SE. Effectiveness of interventions for managing multiple high-burden chronic diseases in older adults: a systematic review and meta-analysis. Can Med Assoc J. 2018 Aug 27;190(34):E1004–12. doi: 10.1503/cmaj.171391.
    1. Viana LV, Gomes MB, Zajdenverg L, Pavin EJ, Azevedo MJ, Brazilian Type 1 Diabetes Study Group Interventions to improve patients' compliance with therapies aimed at lowering glycated hemoglobin (HbA1c) in type 1 diabetes: systematic review and meta-analyses of randomized controlled clinical trials of psychological, telecare, and educational interventions. Trials. 2016 Feb 17;17:94. doi: 10.1186/s13063-016-1207-6.
    1. Parati G, Omboni S. Role of home blood pressure telemonitoring in hypertension management: an update. Blood Press Monit. 2010 Dec;15(6):285–95. doi: 10.1097/MBP.0b013e328340c5e4.
    1. Gabarron E, Årsand E, Wynn R. Social media use in interventions for diabetes: rapid evidence-based review. J Med Internet Res. 2018 Aug 10;20(8):e10303. doi: 10.2196/10303.
    1. Litchman ML, Edelman LS, Donaldson GW. Effect of diabetes online community engagement on health indicators: cross-sectional study. JMIR Diabetes. 2018 Apr 24;3(2):e8. doi: 10.2196/diabetes.8603.
    1. Theng Y, Lee JW, Patinadan PV, Foo SS. The use of videogames, gamification, and virtual environments in the self-management of diabetes: a systematic review of evidence. Games Health J. 2015 Oct;4(5):352–61. doi: 10.1089/g4h.2014.0114.
    1. Faruqui SH, Du Y, Meka R, Alaeddini A, Li C, Shirinkam S, Wang J. Development of a deep learning model for dynamic forecasting of blood glucose level for type 2 diabetes mellitus: secondary analysis of a randomized controlled trial. JMIR Mhealth Uhealth. 2019 Nov 1;7(11):e14452. doi: 10.2196/14452.
    1. Jahmunah V, Oh SL, Wei JK, Ciaccio EJ, Chua K, San TR, Acharya UR. Computer-aided diagnosis of congestive heart failure using ECG signals - a review. Phys Med. 2019 Jun;62:95–104. doi: 10.1016/j.ejmp.2019.05.004.
    1. Weaver RG, Hemmelgarn BR, Rabi DM, Sargious PM, Edwards AL, Manns BJ, Tonelli M, James MT. Association between participation in a brief diabetes education programme and glycaemic control in adults with newly diagnosed diabetes. Diabet Med. 2014 Dec;31(12):1610–4. doi: 10.1111/dme.12513.
    1. Bongaerts BW, Müssig K, Wens J, Lang C, Schwarz P, Roden M, Rathmann W. Effectiveness of chronic care models for the management of type 2 diabetes mellitus in Europe: a systematic review and meta-analysis. BMJ Open. 2017 Mar 20;7(3):e013076. doi: 10.1136/bmjopen-2016-013076.
    1. de Boer IH, Bangalore S, Benetos A, Davis AM, Michos ED, Muntner P, Rossing P, Zoungas S, Bakris G. Diabetes and hypertension: a position statement by The American Diabetes Association. Diabetes Care. 2017 Sep;40(9):1273–84. doi: 10.2337/dci17-0026.
    1. Steinert A, Eicher C, Haesner M, Steinhagen-Thiessen E. Effects of a long-term smartphone-based self-monitoring intervention in patients with lipid metabolism disorders. Assist Technol. 2018 Jun 26;:1–8. doi: 10.1080/10400435.2018.1493710.
    1. Timpel P, Harst L. German Medical Science. GMS Publishing House; 2018. Oct 12, [2020-01-16]. Effectiveness of Telemedicine Interventions for the Most Prevalent Chronic Diseases in German Primary Care – A Protocol for an Umbrella Review .
    1. Battelino T, Danne T, Bergenstal RM, Amiel SA, Beck R, Biester T, Bosi E, Buckingham BA, Cefalu WT, Close KL, Cobelli C, Dassau E, DeVries JH, Donaghue KC, Dovc K, Doyle FJ, Garg S, Grunberger G, Heller S, Heinemann L, Hirsch IB, Hovorka R, Jia W, Kordonouri O, Kovatchev B, Kowalski A, Laffel L, Levine B, Mayorov A, Mathieu C, Murphy HR, Nimri R, Nørgaard K, Parkin CG, Renard E, Rodbard D, Saboo B, Schatz D, Stoner K, Urakami T, Weinzimer SA, Phillip M. Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range. Diabetes Care. 2019 Aug;42(8):1593–603. doi: 10.2337/dci19-0028.
    1. Law LM, Wason JM. Design of telehealth trials--introducing adaptive approaches. Int J Med Inform. 2014 Dec;83(12):870–80. doi: 10.1016/j.ijmedinf.2014.09.002.
    1. Agarwal S, LeFevre AE, Lee J, L'Engle K, Mehl G, Sinha C, Labrique A, WHO mHealth Technical Evidence Review Group Guidelines for reporting of health interventions using mobile phones: mobile health (mHealth) evidence reporting and assessment (mERA) checklist. Br Med J. 2016 Mar 17;352:i1174. doi: 10.1136/bmj.i1174.
    1. Kidholm K, Clemensen J, Caffery LJ, Smith AC. The Model for Assessment of Telemedicine (MAST): A scoping review of empirical studies. J Telemed Telecare. 2017 Oct;23(9):803–13. doi: 10.1177/1357633X17721815.
    1. Enam A, Torres-Bonilla J, Eriksson H. Evidence-based evaluation of eHealth interventions: systematic literature review. J Med Internet Res. 2018 Nov 23;20(11):e10971. doi: 10.2196/10971.
    1. National Institute for Health and Care Excellence National Institute for Health and Care Excellence. 2019. [2020-01-16]. Evidence Standards Framework for Digital Health Technologies (March 2019) .
    1. Eysenbach G, CONSORT-EHEALTH Group CONSORT-EHEALTH: improving and standardizing evaluation reports of Web-based and mobile health interventions. J Med Internet Res. 2011 Dec 31;13(4):e126. doi: 10.2196/jmir.1923.
    1. Clarke M, Williamson PR. Core outcome sets and systematic reviews. Syst Rev. 2016 Jan 20;5:11. doi: 10.1186/s13643-016-0188-6.
    1. Anker SD, Agewall S, Borggrefe M, Calvert M, Caro JJ, Cowie MR, Ford I, Paty JA, Riley JP, Swedberg K, Tavazzi L, Wiklund I, Kirchhof P. The importance of patient-reported outcomes: a call for their comprehensive integration in cardiovascular clinical trials. Eur Heart J. 2014 Aug 7;35(30):2001–9. doi: 10.1093/eurheartj/ehu205.

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir